Journal
JOURNAL OF SCLERODERMA AND RELATED DISORDERS
Volume 2, Issue 1, Pages 11-18Publisher
WICHTIG PUBLISHING
DOI: 10.5301/jsrd.5000231
Keywords
Clinical trials; Modified Rodnan skin score; Skin thickness; Standardization
Categories
Funding
- NIH/NIAMS [K24 AR06312]
Ask authors/readers for more resources
The modified Rodnan skin score (mRSS) is a measure of skin thickness and is used as a primary or secondary outcome measure in clinical trials of systemic sclerosis (scleroderma). This state-of-art review provides a historical perspective of the development of the mRSS, summarizes the performance of mRSS as an outcome measure, provides guidance on assessing mRSS, and makes recommendations for incorporation of the mRSS into clinical trials.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available